YolandaR(Rosi)HelfrichMD
Dermatology • Ann Arbor, MIAcne & Rosacea
Associate Professor; Residency Program Director; Director of Program for Clinical Research in Dermatology
Dr. Helfrich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Education & Training
University of MichiganResidency, Dermatology, 2002 - 2005- University of MichiganInternship, Internal Medicine, 2001 - 2002
University of Michigan Medical SchoolClass of 2001
Swarthmore CollegeBA, Latin major; Ancient History minor, High Honors, 1993 - 1997
Certifications & Licensure
MI State Medical License 2005 - 2027- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis Start of enrollment: 2013 Mar 01
- The Immunological Basis for Treatment Resistance to Anti-TNF Treatments Start of enrollment: 2014 Mar 13
- Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) Start of enrollment: 2016 Oct 20
- Join now to see all
Publications & Presentations
PubMed
- Evaluation of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Subjects With Rosacea.Jessie M Nelson, Jason M Rizzo, Rachel K Greene, Kathryn Fahlstrom, Jonathan P Troost
Cureus. 2024-10-01 - 1 citationsRosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement.McKenzie A Dirr, Areeba Ahmed, Daniel I Schlessinger, Misha Haq, Victoria Shi
JAMA Dermatology. 2024-06-01 - 2 citationsFormylpeptide receptor 1 contributes to epidermal barrier dysfunction-induced skin inflammation through NOD-like receptor C4-dependent keratinocyte activation.Shuai Shao, Zhongbin Sun, Mengyang Chu, Jiaoling Chen, Tianyu Cao
The British Journal of Dermatology. 2024-03-15
Press Mentions
- Does Your Nose Appear Large and Red? You May Have This Type of RosaceaNovember 7th, 2020
National Rosacea Society: New Grants Available in 2019December 19th, 2018
Committees
- Member, AAD Regulatory Policy Committee 2015 - 2017
Professional Memberships
- Fellow
- Member
- Member
- Society of Investigative DermatologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
